4-69107231-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP7BA1
The NM_001074.4(UGT2B7):āc.1059C>Gā(p.Leu353Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.501 in 1,606,936 control chromosomes in the GnomAD database, including 209,705 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as drug response (no stars).
Frequency
Genomes: š 0.59 ( 27852 hom., cov: 31)
Exomes š: 0.49 ( 181853 hom. )
Consequence
UGT2B7
NM_001074.4 synonymous
NM_001074.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.87
Genes affected
UGT2B7 (HGNC:12554): (UDP glucuronosyltransferase family 2 member B7) The protein encoded by this gene belongs to the UDP-glycosyltransferase (UGT) family. UGTs serve a major role in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. This protein is localized in the microsome membrane, and has unique specificity for 3,4-catechol estrogens and estriol, suggesting that it may play an important role in regulating the level and activity of these potent estrogen metabolites. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP7
Synonymous conserved (PhyloP=-2.87 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.759 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UGT2B7 | NM_001074.4 | c.1059C>G | p.Leu353Leu | synonymous_variant | 4/6 | ENST00000305231.12 | NP_001065.2 | |
UGT2B7 | NM_001330719.2 | c.1059C>G | p.Leu353Leu | synonymous_variant | 4/5 | NP_001317648.1 | ||
UGT2B7 | NM_001349568.2 | c.312C>G | p.Leu104Leu | synonymous_variant | 5/7 | NP_001336497.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UGT2B7 | ENST00000305231.12 | c.1059C>G | p.Leu353Leu | synonymous_variant | 4/6 | 1 | NM_001074.4 | ENSP00000304811.7 |
Frequencies
GnomAD3 genomes AF: 0.590 AC: 89584AN: 151736Hom.: 27802 Cov.: 31
GnomAD3 genomes
AF:
AC:
89584
AN:
151736
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.562 AC: 140529AN: 249856Hom.: 41114 AF XY: 0.549 AC XY: 74128AN XY: 135084
GnomAD3 exomes
AF:
AC:
140529
AN:
249856
Hom.:
AF XY:
AC XY:
74128
AN XY:
135084
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.492 AC: 716176AN: 1455080Hom.: 181853 Cov.: 44 AF XY: 0.492 AC XY: 355969AN XY: 724032
GnomAD4 exome
AF:
AC:
716176
AN:
1455080
Hom.:
Cov.:
44
AF XY:
AC XY:
355969
AN XY:
724032
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.591 AC: 89691AN: 151856Hom.: 27852 Cov.: 31 AF XY: 0.598 AC XY: 44404AN XY: 74208
GnomAD4 genome
AF:
AC:
89691
AN:
151856
Hom.:
Cov.:
31
AF XY:
AC XY:
44404
AN XY:
74208
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2215
AN:
3478
ClinVar
Significance: drug response
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Tramadol response Other:1
drug response, no assertion criteria provided | research | Bruce Budowle Laboratory, University of North Texas Health Science Center | Apr 28, 2018 | - T:M1 = postmortem ratio or tramadol to O-desmethyltramadol; t-MP = model-based clustered metabolizer phenotype inferred from T:M1 |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at